Literature DB >> 14959916

Contrast nephropathy after coronary angiography.

Apoor S Gami1, Vesna D Garovic.   

Abstract

Contrast nephropathy after coronary angiography is associated with considerable morbidity and mortality. We discuss the incidence, definition, and pathologic mechanisms of contrast nephropathy; provide an overview of risk factors; highlight proven preventive interventions; clarify which interventions have shown no benefit; and discuss future possibilities. The prevention of contrast nephropathy is crucial for the care of patients undergoing coronary angiography and should be possible with an understanding of risk factors and proven management strategies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14959916     DOI: 10.4065/79.2.211

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  30 in total

Review 1.  Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?

Authors:  Ulf Nyman; Torsten Almén; Bo Jacobsson; Peter Aspelin
Journal:  Eur Radiol       Date:  2012-02-04       Impact factor: 5.315

2.  Trimetazidine in the prevention of contrast-induced nephropathy after coronary procedures.

Authors:  Alper O Onbasili; Yavuz Yeniceriglu; Pinar Agaoglu; Aslihan Karul; Tarkan Tekten; Harun Akar; Guzel Discigil
Journal:  Heart       Date:  2006-10-25       Impact factor: 5.994

3.  Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose.

Authors:  Lu-Ping Li; Tammy Franklin; Hongyan Du; Maria Papadopoulou-Rosenzweig; Joann Carbray; Richard Solomon; Pottumarthi V Prasad
Journal:  J Magn Reson Imaging       Date:  2012-07-23       Impact factor: 4.813

4.  Prospective study of the incidence of contrast-induced nephropathy among patients evaluated for pulmonary embolism by contrast-enhanced computed tomography.

Authors:  Alice M Mitchell; Alan E Jones; James A Tumlin; Jeffrey A Kline
Journal:  Acad Emerg Med       Date:  2012-06       Impact factor: 3.451

5.  Incidence of contrast-induced nephropathy after contrast-enhanced computed tomography in the outpatient setting.

Authors:  Alice M Mitchell; Alan E Jones; James A Tumlin; Jeffrey A Kline
Journal:  Clin J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 8.237

6.  Effect of elective coronary angiography on glomerular filtration rate in patients with advanced chronic kidney disease.

Authors:  Nicola Kumar; Lynn Dahri; Wendy Brown; Neill Duncan; Seema Singh; Christopher Baker; Iqbal Malik; Andrew Palmer; Megan Griffith; Tom Cairns; David Taube
Journal:  Clin J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 8.237

Review 7.  Inhibition of the renin-angiotensin system and chronic kidney disease.

Authors:  Kostas C Siamopoulos; Rigas G Kalaitzidis
Journal:  Int Urol Nephrol       Date:  2008-08-14       Impact factor: 2.370

8.  Contrast administration in pediatric cardiac catheterization: dose and adverse events.

Authors:  Selvi Senthilnathan; Kimberlee Gauvreau; Audrey C Marshall; James E Lock; Lisa Bergersen
Journal:  Catheter Cardiovasc Interv       Date:  2009-05-01       Impact factor: 2.692

9.  The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy.

Authors:  Jordan L Rosenstock; Robert Bruno; Jin K Kim; Lev Lubarsky; Robert Schaller; Georgia Panagopoulos; Maria V DeVita; Michael F Michelis
Journal:  Int Urol Nephrol       Date:  2008-04-26       Impact factor: 2.370

10.  Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: a retrospective cohort study of 7977 patients at mayo clinic.

Authors:  Aaron M From; Brian J Bartholmai; Amy W Williams; Stephen S Cha; Axel Pflueger; Furman S McDonald
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.